Plasma-derived Protein Therapeutics
Kamada is a plasma-derived protein therapeutics company with a commercial product portfolio and a late-stage clinical pipeline. The company uses its proprietary platform technology and expertise for the extraction and purification of proteins from human plasma. The company has two FDA-approved products: GLASSIA, intravenous plasma-derived Alpha-1 Antitrypsi…